NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

So what does LP do, she sells off private U.S. Cognate and builds private UK Advent public Sawston facility.

>>So, with a DC vaccine, like I said, we can just make it ourselves. We can’t scale up as an academic institution or a small company, but if that were part of the company we could scale up. To make the vaccine, you just need a manufacturing GMP facility. But the problem there is the autologous dendritic cells are hard to get patented. You could patent it, but it’s hard to defend that because it’s really the patient’s own tumor, right?
So, the patents really are process patents and we could file one that tweaks things a little bit, and that’s essentially that’s what Northwest Bio did. They filed multiple patents just on little tweaks of the cocktails that are used to make the cells.


>>For instance, consider the trial that I’ve done for dendritic cell vaccines. For cellular therapies, I think what is lacking is a smooth, operational aspect. Let’s say, if there was a company that could make GMP-grade cells readily and basically, it’s almost like the manufacturing, production, distribution, and coordination of the treatment or clinical trial for approval for a treatment would go much more smoothly.
I think that’s what’s lacking. And the ideal company would be like, almost like an Uber or Amazon. Basically something that turns and existing industry upside down. I think we need something that turns the—not only the clinical trial to FDA approval process upside down, but also how to scale that up once something is approved or adopted.

https://billmalloy.info/qa-with-linda-liau/